Pharma & Medications/BioPharma Dive/1d ago

Enhancing Fluid Management Systems to Reduce Variability in Biomanufacturing Processes

In the realm of biomanufacturing, the importance of connectivity in fluid management systems is increasingly recognized as a critical factor influencing process consistency and scalability. As organizations develop complex therapies such as monoclonal antibodies (mAbs), mRNA therapies, and cell therapies, the effectiveness of single-use assemblies becomes paramount. However, the physical connectivity—comprising tubing, connectors, sensors, and fluid transfer paths—often remains underestimated, despite its significant impact on flow behavior and regulatory compliance. Each connection point in a bioprocess can introduce variability, particularly as manufacturing networks expand across multiple sites. Manufacturers face challenges when integrating new equipment or retrofitting existing technologies, leading to a patchwork of connection types and specifications. This complexity can result in unexpected flow behaviors, batch delays, and product loss, prompting manufacturers to question why processes behave differently across locations. The article emphasizes that fluid management is not merely about ensuring compatibility among components; it requires a holistic approach to ensure that the entire manufacturing system operates cohesively. Designing flow kits in isolation can create hidden risks that may only become apparent during real manufacturing conditions. For instance, decisions regarding tubing diameter must consider the entire fluid transfer pathway, including pressure losses over long distances. A well-designed fluid management strategy must account for all components involved in fluid delivery, ensuring predictable manufacturing performance. Cytiva's Batch 360™ service exemplifies a collaborative approach to optimizing single-use consumable packages tailored to specific manufacturing workflows, aiming to reduce complexity and enhance process robustness from development through commercial production.

biomanufacturing / fluid management / process optimization / single-use systems / connectivity

Health Tech

All →

Humana Partners with BlackRock in $2.8B Joint Venture for Senior Primary Care Clinics

Humana has announced a significant joint venture with investment firm BlackRock, which will acquire a majority stake in nearly 150 CenterWell Senior Primary Care clinics for $2.8 billion. This strategic move replaces an existing partnership with Welsh, Carson, Anderson & Stowe (WCAS) and is expected to close by the end of the year. CenterWell will continue to manage the clinics, ensuring that patient care remains unchanged. The deal is part of Humana's broader strategy to enhance its primary care delivery and diversify revenue streams. The joint venture is anticipated to alleviate financial liabilities on Humana's balance sheet, particularly by removing a 'put option' that previously required the company to buy back equity stakes at predetermined prices. This change is expected to provide Humana with greater financial flexibility and lower capital costs. CenterWell, which has expanded to over 350 senior primary care locations, will have the option to purchase clinics from the joint venture starting in 2028, with BlackRock able to exit the partnership by selling remaining clinics if not fully acquired by 2033. Humana's decision to partner with BlackRock, one of the world's largest investment firms, is aimed at accelerating the growth of CenterWell through new clinic developments and acquisitions. The company is set to report its third-quarter earnings on November 6, where investors will be keen to learn more about the implications of this joint venture on CenterWell's performance and the overall financial outlook for Humana, especially following previous losses in 2024 and 2025 due to high medical spending.

Healthcare Dive · 1d ago

Disease & Epidemiology

All →

BlackRock Acquires Majority Stake in Humana's CenterWell Clinics for $2.8 Billion

Humana has announced that BlackRock will acquire a majority stake in its CenterWell Senior Primary Care clinics for $2.8 billion, marking a significant shift in ownership from Welsh, Carson, Anderson & Stowe. This transaction involves a network of 150 clinics that primarily serve Medicare Advantage patients. The deal is expected to enhance Humana's operational capabilities, allowing for the funding of existing clinic operations, the establishment of new clinics, and potential strategic acquisitions over the next two years. The transition comes after Welsh Carson's six-year investment in CenterWell, during which they invested approximately $1.8 billion since 2020. Such moves are typical for private equity firms, which often exit investments after a set period to realize returns. This acquisition by BlackRock, a major player in the investment landscape, underscores the growing interest in healthcare assets, particularly those focused on senior care and Medicare services. The implications of this deal extend beyond financial metrics; it reflects the ongoing trend of private equity involvement in healthcare, which raises questions about the impact on patient care and operational efficiency. As BlackRock steps in, stakeholders will be closely monitoring how this change in ownership affects the quality of care provided at CenterWell clinics and the overall strategy of Humana in the competitive healthcare market.

STAT News · 1d ago

Renowned Infectious Disease Reporter Helen Branswell Passes Away at 69

Helen Branswell, a distinguished reporter known for her insightful coverage of infectious diseases, has died at the age of 69 due to complications from cancer. Her passing marks a significant loss for the public health community and the field of medical journalism. Branswell's career spanned decades, during which she became a trusted source of information on various health crises, including influenza, polio, Ebola, and most notably, Covid-19. Her work was characterized by a commitment to clarity and accuracy, earning her numerous accolades, including the Victor Cohn Prize for Excellence in Medical Science Reporting and a George Polk Award for Public Service. Branswell began her journalism career at a small newspaper in Eastern Canada before joining the Canadian Press, where she initially covered a wide range of topics. Her pivotal moment came during the 2003 SARS outbreak in Toronto, which led her to specialize in infectious diseases. Her ability to distill complex scientific information into accessible narratives made her a vital resource for both the medical community and the general public. During the Covid-19 pandemic, her early insights and timely reporting were particularly influential, with experts praising her foresight and analytical skills. Throughout her career, Branswell's reporting was marked by a dedication to evidence-based journalism. She was known for her ability to anticipate developments in public health and her clear-eyed assessments of emerging threats. Her contributions to the field were recognized not only through awards but also through her role as a trusted voice during critical moments in public health. As the healthcare community mourns her loss, her legacy as a pioneering journalist will continue to inspire future generations of reporters and public health advocates.

STAT News · 1d ago

Analysis Reveals Conflicts of Interest Among FDA Advisory Panel Patient Representatives

A recent analysis published in Health Affairs Scholar highlights significant conflicts of interest within FDA advisory committees, particularly concerning patient and consumer representatives. Over a 20-year period, nearly 40% of these meetings featured representatives linked to advocacy groups funded by pharmaceutical companies, with some committees reporting over 50% such affiliations. Alarmingly, more than 10% of meetings included representatives from organizations that received funding from the specific drug manufacturers whose products were under review. This lack of transparency raises critical questions about the integrity of the advisory process and the potential influence of industry funding on voting behaviors. While the FDA has established conflict-of-interest policies for scientific committee members, the guidelines for patient and consumer representatives remain underdeveloped, particularly regarding the disclosure of industry funding. This situation calls for a reevaluation of policies to ensure unbiased representation in the drug approval process, as the implications of these findings could affect patient safety and trust in the FDA's decision-making.

STAT News · 1d ago

Pharma & Medications

All →

Enhancing Fluid Management Systems to Reduce Variability in Biomanufacturing Processes

In the realm of biomanufacturing, the importance of connectivity in fluid management systems is increasingly recognized as a critical factor influencing process consistency and scalability. As organizations develop complex therapies such as monoclonal antibodies (mAbs), mRNA therapies, and cell therapies, the effectiveness of single-use assemblies becomes paramount. However, the physical connectivity—comprising tubing, connectors, sensors, and fluid transfer paths—often remains underestimated, despite its significant impact on flow behavior and regulatory compliance. Each connection point in a bioprocess can introduce variability, particularly as manufacturing networks expand across multiple sites. Manufacturers face challenges when integrating new equipment or retrofitting existing technologies, leading to a patchwork of connection types and specifications. This complexity can result in unexpected flow behaviors, batch delays, and product loss, prompting manufacturers to question why processes behave differently across locations. The article emphasizes that fluid management is not merely about ensuring compatibility among components; it requires a holistic approach to ensure that the entire manufacturing system operates cohesively. Designing flow kits in isolation can create hidden risks that may only become apparent during real manufacturing conditions. For instance, decisions regarding tubing diameter must consider the entire fluid transfer pathway, including pressure losses over long distances. A well-designed fluid management strategy must account for all components involved in fluid delivery, ensuring predictable manufacturing performance. Cytiva's Batch 360™ service exemplifies a collaborative approach to optimizing single-use consumable packages tailored to specific manufacturing workflows, aiming to reduce complexity and enhance process robustness from development through commercial production.

BioPharma Dive · 1d ago

Clinical Research

All →

Study Links Maternal Opioid Prescriptions to Increased Hospital Admissions in Children in South Korea

A recent nationwide birth cohort study in South Korea has revealed a significant association between maternal opioid prescriptions during pregnancy and an increased risk of hospital admissions in their offspring. The study, which analyzed data from over 2.9 million children born between 2010 and 2017, found that children exposed to opioids in utero had a 28% higher rate of hospital admissions compared to those without such exposure. This risk was shown to be dose-dependent, with higher maternal opioid doses correlating with greater admission rates. The research utilized data from the National Health Insurance Service, tracking children for up to 14 years. It included a comprehensive analysis that adjusted for various confounding factors such as maternal age, socioeconomic status, and pre-existing health conditions. Notably, the increased risk of hospital admissions persisted even after accounting for familial factors in sibling comparison analyses, although the association was somewhat attenuated. The findings indicate that prenatal opioid exposure is linked to higher rates of hospital admissions for various health issues, including infections and respiratory conditions, particularly in the early years of life. The study highlights the importance of monitoring children born to mothers who received opioid prescriptions during pregnancy, suggesting that healthcare providers should consider additional postnatal health checks for these children. While the study provides valuable insights into the long-term impacts of prenatal opioid exposure, it also acknowledges limitations such as reliance on prescription records, which may not accurately reflect actual medication intake. These findings underscore the need for careful consideration of opioid prescriptions in pregnant women and the potential implications for child health.

PLOS Medicine · 1d ago

Health Policy

All →

Bipartisan Efforts Intensify to Address Kids' Online Safety Amid Mental Health Concerns

In a rare display of bipartisan agreement, U.S. Senate candidates in Texas, James Talarico and Ken Paxton, are uniting against the detrimental effects of social media on children's mental health. Talarico advocates for a ban on social media for children under 16 and has co-authored legislation targeting harmful digital content, while Paxton is actively suing major tech companies for their alleged role in exacerbating youth mental health issues. This growing concern is underscored by alarming statistics from the CDC, indicating that one-third of youth experience persistent feelings of sadness or hopelessness, a significant increase over the past decade. The urgency for reform is reflected in the legislative landscape, with at least 35 Senate nominees this year sponsoring bills aimed at regulating social media platforms. The proposed Kids Online Safety Act seeks to implement safeguards to protect minors, including restrictions on communication with them. The bill has garnered substantial support, evidenced by a previous Senate vote that received 91 affirmative votes. As public sentiment shifts against tech companies, with 78% of Americans believing they wield excessive political influence, lawmakers are feeling pressure to act. In response to these developments, major tech firms are ramping up lobbying efforts to influence the regulatory framework. Meta, which recently settled a $17 billion lawsuit, is advocating for parental control over social media access rather than blanket bans. The company has invested heavily in advertising to promote its stance, while also contributing to political campaigns aligned with its interests. As the debate continues, public health advocates are calling for more stringent regulations to mitigate the risks posed by social media, particularly concerning the rise of eating disorders linked to unrealistic portrayals of body image. As Congress moves closer to passing the Kids Online Safety Act, the outcome will likely shape the future of social media regulation and its impact on youth mental health. The ongoing discussions highlight the complexities of balancing technological innovation with the imperative to protect vulnerable populations from potential harm.

KFF Health News · 1d ago

Concerns Rise Over Unregulated Peptide Use Amid Push for Medical Freedom

The use of BPC-157, an unapproved peptide drug, is increasing in the U.S., particularly among white males, as influencers promote its benefits without sufficient clinical evidence. Dylan Meetze, who experienced adverse effects after using BPC-157, highlights the risks associated with these substances. Despite the lack of FDA approval, the Make America Healthy Again (MAHA) movement, led by Health Secretary Robert F. Kennedy Jr., is advocating for easier access to such peptides, arguing for patient autonomy in drug use. Recent developments include a vote by a panel of advisors to the FDA to ease restrictions on several experimental peptides, including BPC-157, despite warnings from FDA scientists about potential health risks and the lack of supporting data. This situation raises concerns about consumer safety and the potential for exploitation in a market driven by unverified claims and profit motives, as regulatory oversight may diminish, leaving patients vulnerable to untested products.

KFF Health News · 1d ago

Navigating Second Opinions in Healthcare: Insights from Experts

Carol Daniel, a broadcast journalist diagnosed with thyroid cancer in 2022, faced the dilemma of seeking a second opinion. Encouraged by her husband, she grappled with feelings of disloyalty towards her primary physician. This scenario is common among patients, as many fear that asking for a second opinion may imply distrust in their current healthcare provider. Family medicine physician Jen Caudle emphasizes that patients should not feel awkward about this request. In her New Jersey practice, she advocates for open communication between patients and their care teams, stating that healthcare providers should support patients in their quest for clarity and confidence in their treatment plans. Caudle suggests that patients view their primary care provider as the central figure in their healthcare journey, akin to a quarterback, who can assist in navigating the complexities of opinions and diagnoses from specialists. This collaborative approach can alleviate the anxiety associated with seeking additional perspectives on medical conditions. The discussion, part of the HealthQ series hosted by Cara Anthony and Blake Farmer, highlights the importance of patient empowerment and the role of primary care in facilitating comprehensive care. As healthcare becomes increasingly complex, fostering open dialogue about second opinions can lead to better patient outcomes and satisfaction.

KFF Health News · 1d ago